Computer Aided Screening of Secreted Frizzled-Related Protein 4 (SFRP4): A Potential Control for Diabetes Mellitus

Molecules

Shazia Anwer Bukhari²  Waseem Akhtar Shamshari²  rib-type="author">Mahmood-Ur-Rahman2Mahmood-Ur-Rahman³  Muhammad Zia-Ul-Haq¹ 

[1] The Patent Office, Karachi 74400, Pakistan;Department of Applied Chemistry and Biochemistry, Government College University, Allama Iqbal Road, Faisalabad 38000, Pakistan; E-Mails:;Department of Bioinformatics and Biotechnology, Government College University, Allama Iqbal Road, Faisalabad 38000, Pakistan; E-Mail:

关键词: bioscreening;    diabetes mellitus;    SFRP4;    cyclothiazide;    clopamide;    perindopril;   

DOI  :  10.3390/molecules190710129

来源: mdpi

【 摘 要 】

Diabetes mellitus is a life threatening disease and scientists are doing their best to find a cost effective and permanent treatment of this malady. The recent trend is to control the disease by target base inhibiting of enzymes or proteins. Secreted frizzled-related protein 4 (SFRP4) is found to cause five times more risk of diabetes when expressed above average levels. This study was therefore designed to analyze the SFRP4 and to find its potential inhibitors. SFRP4 was analyzed by bio-informatics tools of sequence tool and structure tool. A total of three potential inhibitors of SFRP4 were found, namely cyclothiazide, clopamide and perindopril. These inhibitors showed significant interactions with SFRP4 as compared to other inhibitors as well as control (acetohexamide). The findings suggest the possible treatment of diabetes mellitus type 2 by inhibiting the SFRP4 using the inhibitors cyclothiazide, clopamide and perindopril.

【 授权许可】

CC BY   
© 2014 by the authors; licensee MDPI, Basel, Switzerland.